Health ❯Medicine

Pharmaceuticals

Stock Market Public Health Over-the-Counter Medications Regulatory Agencies Adverse Reactions Investment Side Effects Quantum Chemistry Ecosystem Services Lung Diseases

Experimental Diabetes Pill Burns Fat Without Muscle Loss, Advances to Phase II Trial

The oral β2 agonist targets muscle metabolism instead of appetite to improve glycemic control

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control

Medtech Products Recalls Children's Honey Cough Syrup Over Bacterial Contamination

Artificial Enzymes Designed by Computers Rival Natural Catalysts

Democratic-Led States Petition FDA to Remove Mifepristone Restrictions

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial

FDA Commissioner Pledges Safety Review of Abortion Pill Mifepristone

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

FDA Warns of Rare Severe Itching After Stopping Common Allergy Medications

Three Arrested in Selby Over Illegal Slimming Injections After Woman's Hospitalisation

University of Sydney Achieves First Real-Time Quantum Simulation of Molecular Light Reactions

‘Ozempic Mouth’ Identified as New Cosmetic Concern for Weight-Loss Drug Users

New Study Reveals Abortion Pill Complication Rate 22 Times Higher Than FDA Estimate

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

EU Regulators Reject Eli Lilly's Alzheimer's Drug Over Safety Concerns

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

IUCN Red List Identifies 411 Fungi Species at Risk of Extinction

FDA Approves First New Oral Antibiotic for UTIs in Nearly 30 Years

FDA Approves First New Oral Antibiotic for UTIs in Over 20 Years

Amy Schumer Embraces Mounjaro and Hormone Therapy for Improved Health